Business Standard

Tuesday, December 24, 2024 | 04:13 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

India's first indigenous mRNA vaccine likely to be available soon

The Subject Expert Committee (SEC) has recommended granting the Emergency Use Authorisation (EUA) to the country's first mRNA-based Covid-19 vaccine in a meeting held on Friday

Gennova
Premium

Gennova's vaccine has an edge over its international peers as it does not require sub-zero temperatures like Pfizer-BioNTech and Moderna's vaccines

Sohini Das
Soon India may have its first indigenous mRNA vaccine that is stable at 2-8 degrees Celsius as the expert panel advising the Central Drugs Standards Control Organisation (CDSCO) has green-signalled Gennova Biopharma's mRNA vaccine candidate for Covid19.

The Subject Expert Committee (SEC) has recommended granting the Emergency Use Authorisation (EUA) to the country's first mRNA-based Covid-19 vaccine in a meeting held on Friday, according to reports.

Now, the Drugs Controller General of India (DCGI) will take a final call on granting the final approval.

The SEC has reviewed data from the trials done on 4000 volunteers.

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in